Alzheimer’s disease Archives
Alzheimer’s risk factor and cognition
Nov. 8, 2022—Vanderbilt researchers found that a protein with roles in innate immunity worsens memory at baseline in carriers of APOE-e4, the strongest genetic risk factor for Alzheimer’s disease, further implicating neuroinflammation in cognitive decline.
Minority patients less likely to have amyloid plaques necessary for Alzheimer’s treatments
Oct. 3, 2022—Fewer Black, Hispanic and Asian patients meet biomarker qualifications for landmark treatments that may slow the progression of Alzheimer’s disease by targeting amyloid plaques, according to new findings published in JAMA Neurology.
Multisite project seeks to use patients’ voices to help diagnose disease
Sep. 22, 2022—Vanderbilt University Medical Center is partnering with 11 institutions on a $14 million NIH-funded project that aims to establish voice as a biomarker used in clinical care.
Gifts bolster otolaryngology, Alzheimer’s disease programs
Sep. 15, 2022—Herbert Christopher, a grateful Otolaryngology–Head and Neck Surgery patient who received cochlear hearing implants from David Haynes, MD, has funded the training of otolaryngology fellows and leaders in Alzheimer’s disease care through several outright endowed gifts and additional gift planning with his estate.
Today Show: Vanderbilt Memory and Alzheimer’s Center makes national push for clinical study enrollment. You can help.
Jun. 21, 2022—The Today Show’s Maria Shriver spotlighted a landmark, years-long study into the connection between heart health and Alzheimer’s disease, and the urgency to boost study enrollment—particularly among people of color who are disproportionally impacted yet historically underrepresented in research.
Study measures Alzheimer’s risk reductions associated with healthy lifestyles
Jun. 13, 2022—Reported June 13 in Neurology, an Alzheimer’s disease risk study from Vanderbilt University Medical Center measures significantly reduced risk associated with healthy lifestyles, including non-smoking, leisure-time exercise, low-to-moderate alcohol consumption, adequate sleep and healthy diet.
New Clinician Spotlight: Aaron McMurtray
Apr. 26, 2022—Specializing in dementia and Alzheimer’s disease, neurologist Aaron McMurtray, MD, PhD, recently joined Vanderbilt University Medical Center as associate professor of Neurology.
Kalousová, Bolton receive Alzheimer’s Association awards
Apr. 21, 2022—Vanderbilt's Lucie Kalousová, PhD, and Corey Bolton, PsyD, have received research awards from the Alzheimer’s Association.
Event highlights research on Alzheimer’s disease
Apr. 7, 2022—The third annual Vanderbilt Alzheimer’s Disease Research Day featured numerous presentations and concluded with a keynote address by Suzanne Craft, PhD, director of the Alzheimer’s Disease Research Center at Wake Forest University.
PET imaging probe for Alzheimer’s disease
Feb. 24, 2022—Vanderbilt researchers report on a new PET imaging probe that will be useful for exploring Alzheimer’s disease pathology.
Vanderbilt Kennedy Center to host Jan. 25 workshop on Down syndrome and Alzheimer’s disease
Jan. 5, 2022—The Vanderbilt Kennedy Center is teaming up with the Down Syndrome Association of Middle Tennessee to host a virtual workshop on “Risks of Alzheimer’s Disease in Adults with Down Syndrome and Introduction to a Research Study.” The discussion will take place Tuesday, Jan. 25, from 2-3 p.m. CST. Click here to register Down syndrome, or...
“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19
Dec. 10, 2021—Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.